Abstract Submission Information

Days Left to Submit an Abstract


Abstract Submission Opens:

April 1, 2024

Abstract Submission Closes:

11:59 PM ET, Monday, July 1, 2024


Mid-August, 2024

Withdrawal Required by:

11:59 PM ET, Friday, August 25, 2024




Ensure you have all of the information necessary to complete your submission by reviewing the AMP Abstract Prep Guide.

All participants at the AMP 2024 Annual Meeting & Expo are invited to submit abstracts of original studies related to molecular pathology and diagnostics.

Submission Categories
Submission Due Date
Scientific Integrity
Rules for Abstract Submission
Oral Presentations
Additional Information
Author Information


All AMP members may submit abstracts. Non-members may submit an abstract only if an AMP Regular member sponsors their abstract. The AMP Regular member sponsor does not need to be an author on the abstract. If you are not a Member of AMP, join now or renew your 2024 membership to submit your abstract today. You may submit an abstract and apply to join AMP on the same day, up to and through the submission deadline, however, we encourage you to join AMP in advance of the deadline! If you need to renew, log into your account at www.amp.org/myamp and click the Orders/Renewal on the left side menu.


Submission Categories

  • Genetics
  • Hematopathology
  • Infectious Diseases
  • Informatics
  • Solid Tumors
  • Technical Topics
  • Other (e.g. Education)*

*Abstract submissions in the "Other (e.g. Education)" topic category may include descriptions of novel educational approaches, innovative programs, pioneering technologies, etc. As with other abstract submissions, these abstract submissions must demonstrate the scientific method, i.e., describe the methodology and data collection, identify how to measure, analyze, and report outcomes, and provide conclusions. All submitted abstracts will be reviewed with the same criteria (see below).


Submission Due Date

Submission: July 1, 2024 at 11:59 pm (23:59) ET.  NO EXCEPTIONS. The final abstract submission step is not complete until you have clicked the "Submit” button. As you enter information, remember to save your work by clicking the “Save” button, especially before you log out of the system.

Once the abstract is submitted, the Corresponding Author will receive a confirmation email. After the due date, abstracts that are in process and/or saved but not submitted will not be considered for review and/or awards.

Notification: The Corresponding Author will be notified by email in mid-August. Abstracts may be withdrawn until 11:59 pm ET on August 25, 2024.

Embargo: The research presented as posters at the AMP Annual Meeting & Expo from the abstracts published in the November 2024 issue of JMD is embargoed until publication of the abstract to the JMD.

Poster Presentation: First authors of accepted abstracts are expected to register as attendees and present posters at the Annual Meeting & Expo summarizing their studies. Please see the Poster Information page for scheduling information. In addition to presentation of a poster at the 2024 AMP Annual Meeting and Expo, authors will be required to submit an electronic version of their poster for access by attendees of the Annual Meeting and Expo. Details and instructions will follow.


Scientific Integrity

All authors of abstracts must adhere to the AMP Scientific Integrity Policy. All abstracts are held to the same high standard. The perception of bias can sink an abstract submission. Data must be complete (e.g., not indicated as “proprietary”) in the abstract and not merely promised to be in the poster. Assay or platform comparisons must be fair, clear and supported by data from a quality study. We have many excellent submissions from esoteric laboratories and from industry, and these all have in common an absence of specific self-promotion in favor of rigorous, data-driven conclusions without embellishment.


Rules for Abstract Submissions

Note: Abstracts that are not submitted properly will receive an administrative reject and will not be reviewed.

  1. Abstracts must be submitted properly. The online system is a database, with data fields (title, author 1, author 2, author 3, etc.) that are used to generate the published abstracts. Therefore, pay careful attention to the submission instructions and to the submission process, including spelling, capitalization, author names, etc.

  2. The title of the abstract must be in title case, not all capital letters.
  3. All abstracts must include the required headers listed below, so you will enter text under the appropriate header in the submission system. 
    • Introduction: a brief discussion of the background or rationale of the study and/or the question addressed
    • Methods: the experimental approach, materials, and methods used in the study
    • Results: the data and results obtained in the study
    • Conclusions: the conclusions and/or implications of the results

  4. Abstract Limits:
    • Number of authors: 25
    • Abstract Title: 200 characters (including spaces)
    • Abstract Content: 2,800 characters (with spaces and including section headers)

  5. You must include formatting (e.g. italicizing genes), Greek letters and special symbols, e.g. °C (degree sign), superscripts, etc. Data must be reported in narrative format in the abstract submission.

  6. No tables, figures, or references should be included in the abstract. Abstracts for the AMP Annual Meeting and Expo will be published in the Journal of Molecular Diagnostics. To ensure that the meeting abstracts are the same format as journal abstracts, authors should save tables, figures, and references for their presentations and/or posters as well as for full manuscript submissions.

  7. AMP members may submit abstracts. Non-members may submit an abstract only if an AMP Regular member sponsors their abstract. The AMP Regular member sponsor does not need to be an author on the abstract. If you are not a Regular Member of AMP, join now to submit your abstract today. You may submit an abstract and apply to join AMP on the same day, up to and through the submission due date. However, we encourage you to join AMP in advance of the deadline!

  8. Your abstract must be eligible for publication in The Journal of Molecular Diagnostics (JMD):

    • The same abstract submitted to the AMP Annual Meeting & Expo must not have been published elsewhere (including the web), submitted to another publication, or submitted to another meeting that occurs prior to the AMP Annual Meeting. You may, however, submit here if there are new data/findings in this submission. 
    • Abstracts that have been submitted to meetings that occur earlier in the year, should be revised, e.g., with additional data, before submitting to the AMP Annual Meeting and Expo. However, you may submit the same abstract that was presented at the 2024 AMP Europe Meeting.

  9. Your abstract will be rated using four criteria:
    •    Originality and Clarity
    •    Novelty
    •    Scientific Merit/Rigor
    •    Appropriate conclusions

    ABSTRACT REVIEW: Abstracts for the AMP Annual Meeting and Expo will undergo blind review, i.e., the reviewers will not be able to see the names or the affiliations of the abstract author(s). Please refrain from including identifiers in the body of your abstract. The Program Committee will be able to see author and affiliation information after review, during the assignment of platform presentations.

    Summary: Grounds for abstract rejection are:

    • Failure to follow directions in 1-8.
    • The abstract is not eligible for publication in JMD.
    • The abstract contains no scientific data and/or has only a promise of future data.
    • Duplicate abstracts are submitted.
    • The sponsor is not an AMP Regular member.
    • The sponsor or any author violated any of the AMP rules for presentation at a previous meeting, e.g., the authors failed to present a poster without notifying AMP prior to the meeting.
The five most common reasons for rejection are:
  • Previously presented/published data
  • Poor organization/clarity
  • No novel information
  • Insufficient scientific quality
  • Insufficient data
For additional information on best practices for abstract submission, please see the Submission Checklist and FAQ attachments.


Oral Presentations

Platform Presentations are opportunities to give 15-minute oral presentation of your submitted scientific work in front of your scientific peers. Up to 4 abstracts from each category (Genetics, Hematopathology, Infectious Diseases, Informatics, Solid Tumors, and Technical Topics/Other) will be selected. Anyone can be considered for a platform presentation. If selected, you will present your poster AND prepare an oral presentation.


Technologist Innovation Session
(only for AMP Technologist Members)

The Technologist Innovation Session provides an opportunity for AMP Technologist members to highlight their submitted scientific work in a 20-minute oral presentation. Up to 3 abstracts will be selected. If you are an AMP member and your abstract focuses on improvements, optimization, and/or helpful troubleshooting tips for current methods, or a designed of a new process; consider selecting this option. Selected individuals will receive a $1,000 honorarium to cover registration and/or travel expenses. This is only available for AMP Technologist members. If selected, you will present your poster AND prepare an oral presentation for this session. If selected, you will not be eligible to receive a poster or travel award.


Additional Information

Please visit the links below for additional information.


Author Information

  1. The Corresponding (Submitting) Author is the individual who submits the abstract and the contact person for all correspondence from AMP. The Corresponding Author does not need to be the senior author nor do they need to be the first author. The first author is always the presenting author. The Corresponding Author has the following responsibilities and will:
    • Verify that all authors agree at the time of abstract submission that, if accepted, the abstract will be published in The Journal of Molecular Diagnostics (JMD).
    • Verify that all authors agree at the time of abstract submission to transfer all copyright ownership to the Association for Molecular Pathology and the American Society for Investigative Pathology should the abstract be accepted for publication in JMD.
    • Verify that all authors agree to, and any supervisors have given permission for, the presentation of a scientific poster at the annual meeting.
    • Be responsible for notifying all other authors of acceptance, rejection, scheduling and any other information provided by AMP.
    • Be responsible for notifying the Presenting (First) Author of the AMP Rules for Poster Display and any other information provided by AMP. Young Investigator Award applicants are responsible for notifying their faculty mentors of the additional rules for poster display for awards (Awards Information coming soon).
    • Be responsible for compliance with the AMP Scientific Integrity Policy.
  2. The First Author will be the Presenting Author. This author can also be the Corresponding (Submitting) Author. The First (Presenting) Author has the following responsibilities, and will:
    • Register for the Annual Meeting & Expo and attend the poster at the assigned time period to discuss the study and answer questions.* Failure to defend one's study by not attending the poster during the assigned time period is a violation of the AMP Scientific Integrity Policy and can result in forfeiture of future abstract submission privileges.
    • Ensure that the abstract poster conforms to the Rules for Poster Display at the Annual Meeting & Expo (i.e., poster display size, format, and schedule).
  3. Important considerations:
    • Accepted abstracts that have not been previously published as either an abstract or a paper will be eligible for publication in the November 2024 issue of JMD. Abstracts that have been previously published or that are under consideration as an abstract for another meeting that occurs prior to November 2024 will be rejected unless the submitted abstract has new data. 
    • The Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP) are the co-owners of JMD and own the copyright for all manuscripts and abstracts published in the journal. The Corresponding (Submitting) author must verify at the time of abstract submission that, if the abstract is accepted, all authors agree to (1) publication of the abstract in JMD, and (2) transfer copyright ownership to AMP and ASIP. For US government employees, the above assignment applies only to the extent allowed by law. For more information on publication in JMD, please see this link.
    • A disclosure report of relevant financial relationships is required for the Presenting (First) Author of a submitted abstract. The abstract submission site will require the email addresses of all authors. Once the Corresponding Author has entered all co-authors’ names and information, the Corresponding Author can cue the system to notify the co-authors. Employees of commercial entities should disclose employment via this process. Noting the company name in the Author Information field is not sufficient.


*Please note: If the Presenting Author is unable to attend the Annual Meeting to present the poster, every effort should be made to arrange for one of the other authors to present the poster. AMP Education (AMPEducation@amp.org) must be notified that the poster will be presented by another author and provide that author’s information.